VIV — Avivagen Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.39m
- CA$7.61m
- CA$0.94m
- 17
- 51
- 16
- 18
Annual cashflow statement for Avivagen, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2018 October 31st | 2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.83 | -4.84 | -4.75 | -6.39 | -6.07 |
| Depreciation | |||||
| Non-Cash Items | 1.26 | 1.31 | 1.54 | 2.59 | 2.09 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.237 | -0.002 | -0.255 | -0.918 | 0.769 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -3.81 | -3.52 | -3.34 | -4.6 | -3.12 |
| Capital Expenditures | -0.07 | -0.109 | -0.044 | -0.009 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.07 | -0.109 | -0.044 | -0.009 | 0 |
| Financing Cash Flow Items | -0.4 | -2.03 | -0.186 | -0.733 | -0.296 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.48 | 2.51 | 2.96 | 5.35 | 2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.607 | -1.12 | -0.422 | 0.744 | -1.12 |